Recursion (@recursionpharma) 's Twitter Profile
Recursion

@recursionpharma

Decoding biology to radically improve lives. The industrial revolution of drug discovery is here.

ID: 2615770806

linkhttp://www.recursion.com calendar_today10-07-2014 16:41:56

3,3K Tweet

14,14K Takipçi

780 Takip Edilen

Recursion (@recursionpharma) 's Twitter Profile Photo
Recursion
@recursionpharma

2 months ago

Recursion today announced the acquisition of full rights to the REV102 program from Rallybio. REV102 is a potential first-in-class oral ENPP1 inhibitor for the rare genetic disorder Hypophosphatasia (HPP). Learn more: ir.recursion.com/news-releases/…